MedTrace Logo

Systemic Hormones and Muscle Protein Synthesis

NCT03054168 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-02-26

No results posted yet for this study

Summary

This study evaluates the effect of increase in testosterone levels in older males and the effects of decrease in testosterone levels in young males on muscle protein synthesis.

Conditions

Interventions

DRUG

Sustanon 250

The frequency of the injection will be every 2 weeks, 250mg of testosterone, intramuscular injection.

DRUG

Zoladex

The frequency of the injection will be just one injection, 3.6 mg of Zoladex, Subcutaneous injection (abdomen).

OTHER

Placebo

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Philip J Atherton, Professor · The University of Nottingham

  • Nathaniel Szewczyk, Ass. Proff · The University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-15
Primary Completion
2018-11-15
Completion
2019-02-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03054168 on ClinicalTrials.gov